Feasibility Study of the Immunogenicity and Safety of a Novel DTPw/Hib (PRP-T) Brazilian Combination Compared to a Licensed Vaccine in Healthy Children at 2, 4, and 6 Months of Age
Revista da Sociedade Brasileira de Medicina Tropical - Brazil
doi 10.1590/s0037-86822003000300002
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2003
Authors
Publisher
FapUNIFESP (SciELO)